MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
- PMID: 25615422
- DOI: 10.1016/j.canlet.2015.01.015
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
Abstract
MLN4924, a small molecule inhibitor of NEDD8 activating enzyme (NAE), has been reported to elicit an anti-tumor effect on various malignancies. In this study, we investigated the anti-tumor effect of MLN4924 in human urothelial carcinoma (UC) in vitro and in vivo by using three human UC cell lines of various grading (T24, NTUB1 and RT4). The impact of MLN4924 on UC cells was determined by measuring viability (MTT), proliferation (BrdU incorporation), cell cycle progression (flow cytometry with propidium iodide staining) and apoptosis (flow cytometry with annexin V-FITC labeling). The cell cycle regulatory molecules, apoptosis-related molecules, and cell stress-related proteins were examined by Western blotting. The influence of tumor cell migration and invasion was analyzed by Transwell and wound healing assays. We also evaluated the effects of MLN4924 on tumor growth by a SCID xenograft mouse model. The data show that MLN4924 induced dose-dependent cytotoxicity, anti-proliferation, anti-migration, anti-invasion and apoptosis in human UC cells, accompanied by activations of Bad, phospho-histone H2A.X, caspase-3, 7 and PARP, decreased level of phospho-Bcl2, and caused cell cycle retardation at the G2M phase. Moreover, MLN4924 activated endoplasmic reticulum stress-related molecules (caspase-4, phospho-eIF2α, ATF-4 and CHOP) and other stress responses (JNK and c-Jun activations). Finally, we confirmed MLN4924 inhibited tumor growth in a UC xenograft mouse model with minimal general toxicity. We concluded that MLN4924 induces apoptosis and cell cycle arrest, as well as activation of cell stress responses in human UC. These findings imply MLN4924 provides a novel strategy for the treatment of UC.
Keywords: Apoptosis; MLN4924; Neddylation; Urothelial carcinoma.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.Cancer Chemother Pharmacol. 2018 Jun;81(6):1083-1093. doi: 10.1007/s00280-018-3582-z. Epub 2018 Apr 17. Cancer Chemother Pharmacol. 2018. PMID: 29667067
-
MLN4924, a Protein Neddylation Inhibitor, Suppresses the Growth of Human Chondrosarcoma through Inhibiting Cell Proliferation and Inducing Endoplasmic Reticulum Stress-Related Apoptosis.Int J Mol Sci. 2018 Dec 24;20(1):72. doi: 10.3390/ijms20010072. Int J Mol Sci. 2018. PMID: 30586948 Free PMC article.
-
MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma.Sci Rep. 2017 Jul 17;7(1):5599. doi: 10.1038/s41598-017-06098-y. Sci Rep. 2017. PMID: 28717191 Free PMC article.
-
The Double-Edged Effects of MLN4924: Rethinking Anti-Cancer Drugs Targeting the Neddylation Pathway.Biomolecules. 2024 Jun 21;14(7):738. doi: 10.3390/biom14070738. Biomolecules. 2024. PMID: 39062453 Free PMC article. Review.
-
Neddylation-Independent Activities of MLN4924.Adv Exp Med Biol. 2020;1217:363-372. doi: 10.1007/978-981-15-1025-0_21. Adv Exp Med Biol. 2020. PMID: 31898238 Review.
Cited by
-
Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells.Oncotarget. 2016 Oct 4;7(40):66087-66099. doi: 10.18632/oncotarget.11807. Oncotarget. 2016. PMID: 27602774 Free PMC article.
-
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings.Sci Rep. 2018 Feb 1;8(1):2082. doi: 10.1038/s41598-018-19628-z. Sci Rep. 2018. PMID: 29391477 Free PMC article.
-
Inhibition of Neddylation Suppresses Osteoclast Differentiation and Function In Vitro and Alleviates Osteoporosis In Vivo.Biomedicines. 2022 Sep 21;10(10):2355. doi: 10.3390/biomedicines10102355. Biomedicines. 2022. PMID: 36289618 Free PMC article.
-
Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL.Cell Death Differ. 2022 Aug;29(8):1654-1668. doi: 10.1038/s41418-022-00955-8. Epub 2022 Feb 22. Cell Death Differ. 2022. PMID: 35194189 Free PMC article.
-
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: in vitro and in vivo study.Am J Cancer Res. 2015 Oct 15;5(11):3350-62. eCollection 2015. Am J Cancer Res. 2015. PMID: 26807316 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous